Inficure Bio has signed a contract for global collaboration through which CSL will use Inficure’s N-IF test model.
Francis H. Arnold is the fifth women to be awarded the Nobel prize in chemistry and is one of the customers to the Umeåbased company SpinChem.
Umeå and Gothenburg, Sweden, are two of the 12 cities in the final to be European Capital of Innovation.
Quretech Bio has reached a milestone in its development. Recently, the company took its first investment capital and a cunning business development partner.
12 business ideas will tested and developed during the Startup Program this fall. A wide range of ideas and enthusiastic participants indicate that the upcoming months will be both intense and inspiring. Now the work begins, the goal is to find out if the ideas have potential or not.
Startups and companies from northern Sweden now have the chance to accompany Medica in Germany, one of the world's largest medical fairs.
The Umeåbased startup company Lipum has been granted 2,2 milion euro from EU for the development of a new drug for patients suffering from chronic inflammatory diseases.
Umeå in Sweden is one of the finalist cities of this year’s European Capital of Innovation Award.
Umeå region’s life science companies and Umeå Biotech Incubator (UBI) have generated great successes during recent years.
This summer 24 students have been accepted as summer entreprenuers and will work as a consultants in companies in need of their competence.
InfiCure Bio’s objective is to stop fibrosis, an illness that causes 40 percent of all deaths in the western world. To help them, they have the unique N-IF mouse.